Flowcytometric assessment of monocyte-derived dendritic cell efficiency for tumor cell lysate uptake in chronic lymphocytic leukemia patients

Author(s):
Parviz KokhaeiParviz Kokhaei,*, Reza MahdianReza Mahdian, Fateme PakFateme Pak, Shirin ShahbaziShirin Shahbazi, Bizhan SedighiMoghadamBizhan SedighiMoghadam

Koomesh:Vol. 4, issue 1; 29-38
Published online:Aug 30, 2002
Article type:Research Article
How to Cite:Kokhaei P, Mahdian R, Pak F, Shahbazi S, SedighiMoghadam B. Flowcytometric assessment of monocyte-derived dendritic cell efficiency for tumor cell lysate uptake in chronic lymphocytic leukemia patients. koomesh. 2002;4(1):e151962. doi:

Abstract

Similar Articles

2
Aug
2021

Effect of IL-27 on activity of bone marrow NK cells of patient with B-chronic lymphocytic leukemia in vitro

Abdolvahid Sadeghnejad,
Maral Hemati,
Mehrnoosh Pashaei,
Zahra Rasouli Nejad,
Farahnaz Ghahremanfard,
Parviz Kokhaei

Sadeghnejad A, Hemati M, Pashaei M, Rasouli Nejad Z, Ghahremanfard F, et al. Effect of IL-27 on activity of bone marrow NK cells of patient with B-chronic lymphocytic leukemia in vitro. koomesh. 2021;23(1):e153248. doi:

12
Aug
2025
Iran J Pharm Res

Expression Modulation of Immune Inhibitory Molecules by Small Molecule Inhibitor Drugs in Leukemic Cells of Chronic Lymphocytic Leukemia

Fatemeh Mousavi-Mirkalaei,
Saeid Taghiloo,
Maryam Alizadeh-Foroutan,
Ehsan Zaboli,
Mohammad Eslami-Jouybari,
Ramin Shekarriz
,et al.

Mousavi-Mirkalaei F, Taghiloo S, Alizadeh-Foroutan M, Zaboli E, Eslami-Jouybari M, et al. Expression Modulation of Immune Inhibitory Molecules by Small Molecule Inhibitor Drugs in Leukemic Cells of Chronic Lymphocytic Leukemia. Iran J Pharm Res. 2025;24(1):e159353. doi: https://doi.org/10.5812/ijpr-159353

28
Sep
2015

Therapeutic effects of fludarabine-cyclophosphamide combined therapy in Iranian patients with B-cell chronic lymphocytic leukemia

Kamran Moshfeghi,
Dr Ghasem Mosayebi

Moshfeghi K, Mosayebi DG. Therapeutic effects of fludarabine-cyclophosphamide combined therapy in Iranian patients with B-cell chronic lymphocytic leukemia. koomesh. 2015;16(2):e151299. doi:

21
May
2014

The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia

Fatemeh M. Kamazani,
Gholamreza Bahoush-Mehdiabadi,
Mahnaz Aghaeipour,
Shahram Vaeli,
Zahra Amirghofran

M. Kamazani F, Bahoush-Mehdiabadi G, Aghaeipour M, Vaeli S, Amirghofran Z. The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia. Inn J Pediatr. 2014;24(4):. doi:

5
Dec
2018

Flow Cytometry of CD64, HLA-DR, CD25, and TLRs for Diagnosis and Prognosis of Sepsis in Critically Ill Patients Admitted to the Intensive Care Unit: A Review Article

Ata Mahmoodpoor,
Seyedpouya Paknezhad,
Kamran Shadvar,
Hadi Hamishehkar,
Ali Akbar Movassaghpour,
Sarvin Sanaie
,et al.

Mahmoodpoor A, Paknezhad S, Shadvar K, Hamishehkar H, Movassaghpour AA, et al. Flow Cytometry of CD64, HLA-DR, CD25, and TLRs for Diagnosis and Prognosis of Sepsis in Critically Ill Patients Admitted to the Intensive Care Unit: A Review Article. Anesth Pain Med. 2018;8(6):e83128. doi: https://doi.org/10.5812/aapm.83128

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles